Integrated Proteins Limited (BOM:519606)
136.60
+2.65 (1.98%)
At close: May 29, 2026
Integrated Proteins Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
Operating Revenue | 257.32 | 214.96 | 2.37 | 1.67 | - | - |
Other Revenue | -0 | -0 | - | - | - | - |
| 257.32 | 214.96 | 2.37 | 1.67 | - | - | |
Revenue Growth (YoY) | 10317.81% | 8954.84% | 42.16% | - | - | - |
Cost of Revenue | 250.7 | 210.25 | 2.22 | 1.47 | - | - |
Gross Profit | 6.63 | 4.71 | 0.15 | 0.2 | - | - |
Selling, General & Admin | 0.31 | 0.21 | 0.62 | 0.04 | 0.14 | 0.22 |
Other Operating Expenses | 3.56 | 3.5 | 0.71 | 1.01 | 0.64 | 0.8 |
Operating Expenses | 3.87 | 3.8 | 1.6 | 1.34 | 1.06 | 1.31 |
Operating Income | 2.76 | 0.91 | -1.45 | -1.14 | -1.06 | -1.31 |
Interest Expense | - | - | - | - | -0 | - |
Interest & Investment Income | 1.53 | 1.53 | 1.56 | 1.56 | 1.56 | 1.6 |
Other Non Operating Income (Expenses) | -1.98 | - | -0 | -0 | 0 | - |
EBT Excluding Unusual Items | 2.3 | 2.44 | 0.11 | 0.42 | 0.49 | 0.29 |
Gain (Loss) on Sale of Assets | 0.75 | 0.75 | 0.93 | - | - | - |
Pretax Income | 3.05 | 3.19 | 1.04 | 0.42 | 0.49 | 0.29 |
Income Tax Expense | 0.58 | 0.69 | 0.15 | 0.11 | 0.13 | 0.08 |
Net Income | 2.47 | 2.5 | 0.89 | 0.31 | 0.37 | 0.21 |
Net Income to Common | 2.47 | 2.5 | 0.89 | 0.31 | 0.37 | 0.21 |
Net Income Growth | 340.82% | 179.95% | 189.00% | -15.34% | 72.17% | 281.19% |
Shares Outstanding (Basic) | 3 | 4 | 3 | 3 | 3 | 3 |
Shares Outstanding (Diluted) | 3 | 4 | 3 | 3 | 3 | 3 |
Shares Change (YoY) | 4.74% | 9.88% | - | - | -0.01% | 0.01% |
EPS (Basic) | 0.75 | 0.71 | 0.28 | 0.10 | 0.11 | 0.07 |
EPS (Diluted) | 0.75 | 0.71 | 0.25 | 0.09 | 0.11 | 0.07 |
EPS Growth | 320.24% | 184.00% | 177.78% | -21.01% | 72.19% | 281.15% |
Gross Margin | 2.57% | 2.19% | 6.36% | 11.98% | - | - |
Operating Margin | 1.07% | 0.43% | -60.91% | -68.08% | - | - |
Profit Margin | 0.96% | 1.16% | 37.62% | 18.50% | - | - |
EBITDA | 2.73 | 1.01 | -1.18 | -0.85 | -0.77 | -1.02 |
EBITDA Margin | 1.06% | 0.47% | -49.79% | -50.84% | - | - |
D&A For EBITDA | -0.03 | 0.1 | 0.26 | 0.29 | 0.29 | 0.29 |
EBIT | 2.76 | 0.91 | -1.45 | -1.14 | -1.06 | -1.31 |
EBIT Margin | 1.07% | 0.43% | -60.91% | -68.08% | - | - |
Effective Tax Rate | 19.00% | 21.73% | 14.05% | 26.08% | 26.11% | 26.13% |
Revenue as Reported | 257.71 | 217.34 | 4.86 | 3.23 | 1.56 | 1.6 |
Advertising Expenses | - | 0.05 | 0.01 | 0.01 | 0.01 | 0.01 |